| Financial Year |
March 31 2023 |
| Monetary Funds |
1,310,239,284.89 |
| Held-for-trading Financial Assets |
31,014,176.99 |
| Notes Receivable |
-- |
| Accounts Receivable |
37,105,897.15 |
| Advances to Suppliers |
5,714,315.92 |
| Other Receivables |
8,085,383.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
99,302,552.75 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
226,446,083.10 |
| Total Current Assets |
1,718,707,694.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
36,421,888.75 |
| Fixed Assetes |
465,107,416.01 |
| Under-construction Projects |
2,228,679.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,528,508.88 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
175,745.97 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
3,952,710.24 |
| Sub-Total of Non-Current Assets |
563,414,949.36 |
| Total Assets |
2,282,122,643.93 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
92,730,761.52 |
| Accounts Payable |
76,430,290.74 |
| Accounts Received In Advance |
755,146.15 |
| Employee Compensation Payable |
11,619,579.51 |
| Taxes Payable |
35,669,823.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
47,600,767.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
6,575,646.42 |
| Sub-Total of Current Liabilities |
303,877,003.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,313,715.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,423,357.11 |
| Total Liabilities |
319,300,360.88 |
| Paid-In Capital(Or Share Stock) |
184,609,425.00 |
| Capital Surplus |
1,006,612,951.66 |
| Surplus Reserve |
92,304,712.50 |
| LESS:Treasury Stock |
12,058,130.00 |
| Undistributed Profits |
691,353,323.89 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,962,822,283.05 |
| Owner's Equity（Stockholder's Equity） |
1,962,822,283.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,282,122,643.93 |
